Dave Nichols

Dave Nichols

Chief Technical Officer

As Chief Technical Officer, Mr. Nichols leads all of Magenta’s CMC activities from early development through commercial products across the company’s pipeline, including driving strategic initiatives to improve efficiency, consistency, compliance and risk mitigation for Magenta’s antibody drug conjugate, cell therapy, and peptide manufacturing processes.

Mr. Nichols has more than 25 years of experience in biologics process development across the life sciences industry. Most recently, Mr. Nichols served as Senior Vice President of Kiniksa Pharmaceuticals, Ltd., where he was responsible for all process development and internal and external GMP manufacturing. Previously, he served as Head of CMC Biologicals Drug Substances at Tesaro Pharmaceuticals; Senior Director of Process Development at Operations at Teva Pharmaceuticals; Senior Director, CMC Integration at Shire Pharmaceuticals, among other titles of increasing responsibilities at the organization.

Mr. Nichols holds an MBA from Northeastern University and a Masters in Biochemistry from the University of New Hampshire.